輸入代號或公司名稱後按 Enter
1788

杏昌

0.00 (0.00%)最後更新 2026-09-11
台灣 · 上櫃 · 生技醫療業
128.0014成交張數14.55本益比1.93股價淨值比5.47%殖利率2026-09-11資料日期

每股盈餘

柱為單季 EPS,線為近四季合計;近十年

季度單季 EPS年增近四季 EPS歸屬母公司淨利(億)淨利率ROE(季)ROE(近四季)
2026Q22.294.1%8.811.029.2%3.33%13.48%
2026Q12.3423.2%8.721.049.1%3.36%12.44%
2025Q42.0425.9%8.280.918.3%3.02%12.18%
2025Q32.1415.7%7.860.958.9%3.26%11.83%
2025Q22.20-10.2%7.570.989.2%3.30%11.74%
2025Q11.90-12.0%7.820.858.1%2.78%11.29%
2024Q41.62-12.9%8.080.727.2%2.42%12.02%
2024Q31.85-5.6%8.320.828.2%2.83%12.64%
2024Q22.4517.8%8.431.099.9%3.66%13.19%
2024Q12.162.4%8.060.9610.0%3.17%11.85%
2023Q41.86-15.5%8.010.838.4%2.81%12.83%
2023Q31.9620.4%8.350.888.9%3.07%13.37%
2023Q22.08-30.0%8.020.929.7%3.18%12.95%
2023Q12.11-6.6%8.910.858.8%3.15%13.30%
2022Q42.20-1.7%9.060.868.9%3.58%15.45%
2022Q31.63-22.9%9.100.676.8%2.88%16.30%
2022Q22.9724.9%9.581.226.9%5.18%16.99%
2022Q12.265.5%8.990.929.4%3.88%15.63%
2021Q42.246.1%8.870.9110.1%4.02%16.15%
2021Q32.11-15.1%8.740.849.3%3.72%16.50%
2021Q22.387.1%9.120.929.3%4.16%17.25%
2021Q12.1419.9%8.960.829.3%3.92%16.65%
2020Q42.117.5%8.610.809.3%4.10%16.71%
2020Q32.4973.8%8.460.9110.4%5.08%17.16%
2020Q22.2235.5%7.400.819.3%4.53%15.98%
2020Q11.790.0%6.820.657.9%3.59%13.92%
2019Q41.969.4%6.820.728.8%4.09%14.35%
2019Q31.43-1.5%6.650.526.5%3.10%14.46%
2019Q21.64-14.4%6.670.597.1%3.48%14.87%
2019Q11.797.1%6.950.637.8%3.78%14.67%
2018Q41.80-12.0%6.830.648.1%3.98%14.91%
2018Q31.45-5.1%7.070.516.7%3.31%16.10%
2018Q21.917.7%7.150.698.9%4.29%16.86%
2018Q11.67-1.2%7.010.597.7%3.61%15.26%
2017Q42.0412.4%7.030.739.8%4.59%15.79%
2017Q31.532.0%6.810.557.2%3.57%15.96%
2017Q21.7864.5%6.780.638.5%4.07%16.45%
2017Q11.6918.6%6.080.608.5%3.80%13.61%
2016Q41.815.820.659.0%4.26%
2016Q31.500.537.5%3.64%